Literature DB >> 10071767

Phosphorylation and recycling kinetics of G protein-coupled receptors.

G Innamorati1, H Sadeghi, M Birnbaumer.   

Abstract

The rate of ligand-induced phosphorylation of the V2 and V1a vasopressin receptors was characterized in HEK 293 cells. Both receptors were phosphorylated predominantly by GRKs, and the V1a receptor was also phosphorylated by protein kinase C regardless of the presence or absence of ligand. Phosphorylation of the V1aR catalyzed by GRKs reached maximal values at the shortest measured time: 15 seconds, and decayed rapidly with a t1/2 of 6 min in the continuous presence of AVP. In agreement with the hypothesis that dephosphorylation must precede receptor recycling to the cell surface, the V1aR returned rapidly to the cell surface after removal of the hormone from the medium. Phosphate incorporation into the V2R proceeded at a slower pace, and the internalized phosphorylated receptor failed to recycle to the cell surface and retained its phosphate for a long time in the presence or absence of ligand. A single mutation in the carboxy terminus of the V2R accelerated de-phosphorylation of the protein and conferred recycling properties to the V2R. These experiments provided molecular evidence for the hypothesis that internalization is required for de-phosphorylation and recycling of reactivated G protein coupled receptors to the cell surface.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10071767     DOI: 10.3109/10799899909036654

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  8 in total

1.  Down-modulation of the G-protein-coupled estrogen receptor, GPER, from the cell surface occurs via a trans-Golgi-proteasome pathway.

Authors:  Shi-Bin Cheng; Jeffrey A Quinn; Carl T Graeber; Edward J Filardo
Journal:  J Biol Chem       Date:  2011-05-02       Impact factor: 5.157

2.  Visualizing microtubule-dependent vasopressin type 2 receptor trafficking using a new high-affinity fluorescent vasopressin ligand.

Authors:  Sylvia Chen; Matthew J Webber; Jean-Pierre Vilardaga; Ashok Khatri; Dennis Brown; Dennis A Ausiello; Herbert Y Lin; Richard Bouley
Journal:  Endocrinology       Date:  2011-08-09       Impact factor: 4.736

Review 3.  New insights into the dynamic regulation of water and acid-base balance by renal epithelial cells.

Authors:  Dennis Brown; Richard Bouley; Teodor G Păunescu; Sylvie Breton; Hua A J Lu
Journal:  Am J Physiol Cell Physiol       Date:  2012-03-28       Impact factor: 4.249

4.  Chronic adrenaline treatment fails to down-regulate the Del301-303-alpha2B-adrenoceptor in neuronal cells.

Authors:  S Salim; A N Desai; M Taneja; D C Eikenburg
Journal:  Br J Pharmacol       Date:  2009-09       Impact factor: 8.739

5.  Sex-Specific Vasopressin Signaling Buffers Stress-Dependent Synaptic Changes in Female Mice.

Authors:  Spencer P Loewen; Dinara V Baimoukhametova; Jaideep S Bains
Journal:  J Neurosci       Date:  2020-10-13       Impact factor: 6.167

Review 6.  Arginine vasopressin receptor signaling and functional outcomes in heart failure.

Authors:  Melissa A Wasilewski; Valerie D Myers; Fabio A Recchia; Arthur M Feldman; Douglas G Tilley
Journal:  Cell Signal       Date:  2015-07-30       Impact factor: 4.315

7.  Arginine vasopressin enhances cell survival via a G protein-coupled receptor kinase 2/β-arrestin1/extracellular-regulated kinase 1/2-dependent pathway in H9c2 cells.

Authors:  Weizhong Zhu; Douglas G Tilley; Valerie D Myers; Ryan C Coleman; Arthur M Feldman
Journal:  Mol Pharmacol       Date:  2013-05-20       Impact factor: 4.436

Review 8.  Science review: Vasopressin and the cardiovascular system part 1--receptor physiology.

Authors:  Cheryl L Holmes; Donald W Landry; John T Granton
Journal:  Crit Care       Date:  2003-06-26       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.